Business
Continued from page 49
19 Petterson, M et al. PROteolysis TArgeting Chimeras (PROTACs) – Past, present and future. Drug Discovery Today: Technologies – Volume 31, April 2019, Pages 15-27
https://doi.org/10.1016/j.ddtec.2019.01.002. 20 How does gene therapy work? National Library of Medicine (US). Genetics Home Reference [Internet]. Bethesda (MD): The Library; 2019 Sep 10. Available from: https://
ghr.nlm.nih.gov/primer/therapy/procedures. 21 CAR-T Therapy. NHS England.
https://www.england.nhs.uk/cancer/cdf/ car-t-therapy/. 22 Biehl, J et al. Introduction to Stem Cell Therapy. he Journal of Cardiovascular Nursing. 24(2):98-103, March-April 2009.
https://DOI.org/ 10.1097/JCN.0b013e318197a6a5. 23 Rettner, R. Live Science. April 18, 2019. Rare ‘Bubble Boy Disease’ Likely Cured with New Gene Therapy.
https://www.livescience.com/
65270-bubble-boy-disease-gene-therapy.html. 24 FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss.
https://www.fda.gov/news-events/press- announcements/fda-approves-novel-gene- therapy-treat-patients-rare-form-inherited- vision-loss. 25Wall Street Wants the Best Patents, Not the Best Drugs.
https://www.bloomberg.com/ opinion/articles/2018-11-27/gilead-s-cures-for- hepatitis-c-were-not-a-great-business-model. 26 Keohane, N et al. Outcomes-based reimbursement of medicines. Social Market Foundation. August 2017.
http://www.smf.co.uk/ wp-content/uploads/2017/07/Data-for- Outcomes-final.pdf. 27 Jørgensen, Jesper and Kefalas, Panos (2017). Annuity payments can increase patient access to innovative cell and gene therapies under England’s net budget impact test. Journal of Market Access & Health Policy. Volume 5, 2016 – Issue 1.
https://doi.org/10.1080/20016689. 2017.1355203. 28 Beasley, D et al. Novartis pitches discounts on pricey gene therapy for deadly muscle disorder. Reuters May 10, 2019.
https://uk.reuters.com/article/uk-novartis-sma- insurers-exclusive/exclusive-novartis-pitches- discounts-on-pricey-gene-therapy-for-deadly- muscle-disorder-idUKKCN1SG22C. 29 Schroeder, B et al. Signals from the gut microbiota to distant organs in physiology and disease. Nature Medicine volume 22, pages 1079-1089 (2016). https://doi/10.1038/nm.4185. 30 Fernandez, C. No Guts, No Glory: How Microbiome Research is Changing Medicine.
Labiotech.eu (2019).
https://labiotech.eu/ features/gut-microbiome-research/. 31 Saji, N, Niida, S, Murotani, K et al. Analysis of the relationship between the gut microbiome and dementia: a cross-sectional study conducted in Japan. Sci Rep 9, 1008 (2019) doi:10.1038/s41598-018-38218-7.
50
32 Diagnostic Pill Samples Bacteria While Traveling Inside Gut. Medgadget. (2019).
https://www.medgadget.com/2019/07/diagnostic- pill-samples-bacteria-while-traveling-inside-
gut.html. 33 Nejad, H et al. Ingestible Osmotic Pill for In vivo Sampling of Gut Microbiome. Adv. Intell. Syst. 2019, 1, 1900053.
https://doi.org/10.1002/ aisy.201900053. 34 UK Govt Department of Health & Social Care “Prevention is better than cure – Our vision to help you live well for longer” (2018) –
https://assets.publishing.service.gov.uk/governme nt/uploads/system/uploads/attachment_data/file/ 753688/Prevention_is_better_than_cure_5- 11.pdf. 35 Byrd, A, Belkaid, Y and Segre, J. The human skin microbiome. Nat Rev Microbiol 16, 143- 155 (2018) doi:10.1038/nrmicro.2017.157. 36 Nakatsuji, T et al. A commensal strain of Staphylococcus epidermidis protects against skin neoplasia. Science Advances 28 Feb 2018: Vol. 4, no. 2, eaao4502 DOI: 10.1126/sciadv.aao4502
https://advances.sciencemag.org/content/4/2/ eaao4502. 37 University of Oxford. MSc in Nanotechnology for Medicine and Health Care.
https://www.ox.ac.uk/admissions/graduate/cours es/msc-nanotechnology-for-medicine-and-health- care?wssl=1. 38 Harvard University. CRISPR: Gene-editing Applications – https://online-learning.
harvard.edu/course/crispr-gene-editing- applications?delta=0. 39 Driving Innovation And Economic Growth For The 21st Century State Efforts To Attract And Grow The Biopharmaceutical Industry
https://www.phrma.org/-/media/Project/PhRMA/ PhRMA-Org/PhRMA-Org/PDF/PhRMA-Driving- Innovation_06_012017.pdf. 40 Bridging the skills gap in the biopharmaceutical industry: Maintaining the UK’s leading position in life sciences –
https://www.abpi.org.uk/media/6657/ 190124-final-abpi-bridging-the-gap-in-the- biopharmaceutical-industry_v3.pdf. 41 Rang, H. Bad Pharma: how drug companies mislead doctors and harm patients. Br J Clin Pharmacol. 2013;75(5):1377-1379. doi:10.1111/bcp.12047. 42 Dyer, O. Dozens of US states sue 20 generic drug companies over “industry wide conspiracy” to drive up prices BMJ 2019;365:l2215.
https://www.bmj.com/content/365/bmj.l2215. 43 Computer, Restaurant Sectors Still Top- Rated U.S. Industries (2018).
https://news.gallup.com/poll/241892/computer-
restaurant-sectors-top-rated-industries.aspx. 44 9 Must-have skills you need to become a Data Scientist. KDNuggets (2018).
https://www.kdnuggets.com/2018/05/simplilearn-
9-must-have-skills-data-scientist.html. 45The European Federation Of Statisticians In The Pharmaceutical Industry (EFSPI)
https://www.efspi.org/Documents/About/EFSPI% 20constitution%202018.pdf.
46 Hiring and Beyond: How to Resource Data Scientists in your Business. Frontline Genomics (2019).
http://www.frontlinegenomics.com/ news/27331/hiring-and-beyond-how-to- resource-data-scientists-in-your-business/. 47 Rowell, A. Adaptive licensing: a model approach? (2019). https://united-
kingdom.taylorwessing.com/synapse/regulatory_
adaptivelicense.html. 48 EMA Regulatory Science to 2025 – Strategic Reflection. European Medicines Agency (2018).
https://www.ema.europa.eu/en/documents/regul atory-procedural-guideline/ema-regulatory- science-2025-strategic-reflection_en.pdf. 49 Framework for the Regulation of Regenerative Medicine Products. FDA (2019).
https://www.fda.gov/vaccines-blood- biologics/cellular-gene-therapy- products/framework-regulation-regenerative- medicine-products. 50 Cellular & Gene Therapy Guidances. FDA (2019).
https://www.fda.gov/vaccines-blood- biologics/biologics-guidances/cellular-gene- therapy-guidances. 51 CMS Law – New Trends: Reform to Drugs and Medical Devices in China (2017).
https://www.cms-lawnow.com/ealerts/2017/11/ new-trends-reform-to-drugs-and-medical- devices-in-china?cc_lang=en. 52 NICE – About.
https://www.nice.org.uk/about. 53 ICHOM. International Consortium for Health Outcomes Measurement.
https://www.ichom.org/mission/. 54 European Network for Health Technology Assessment.
https://www.eunethta.eu/. 55 Lesser, N. How biopharmaceutical collaborations are fueling biomedical innovation. Deloitte.
https://www2.deloitte.com/us/en/ pages/life-sciences-and-health-care/articles/how- biopharma-collaborations-are-fueling-
biomedical-innovation.html. 56 Open Targets
https://www.opentargets.org/. 57 van den Heuvel, R et al (2018). R&D 2030 – Reinvent innovation and become an R&D front- runner by 2030. KPMG
https://assets.kpmg/ content/dam/kpmg/xx/pdf/2018/11/r-and-d- 2030-thriving-on-disruption-series.pdf. 58The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH).
https://www.ich.org/. 59Towards Access 2030: WHO Essential Medicines and Health Products Strategic Framework 2016-2030. Geneva: World Health Organization; 2017 (WHO/EMP/2017.01). Licence: CC BY-NC-SA 3.0 IGO.
https://www.who.int/medicines/publications/ Towards_Access_2030_Final.pdf.
Drug Discovery World Winter 2019/20
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68